tirzepatide for psoriatic arthritis π¨ First-of-its-kind Phase 3b data: treating obesity improves outcomes Today, Eli Lilly and Company announced positive topline results from TOGETHER-PsA, the first controlled trial evaluating an incretin therapy used alongside Study: GLP-1 Drug Plus Biologic
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19










.png?sfvrsn=445e9145_3)
















